NIKOLAOS VOULGARIS

Mr. NIKOLAOS VOULGARIS

Sustainable Energy and Environmental Engineering, Osaka University, Ōsaka, Japan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Cells
Verified
Journal Article
Open access
PDF file
Sachie KusakaSachie Kusaka
Sachie Kusaka
NIKOLAOS VOULGARISNIKOLAOS VOULGARIS
NIKOLAOS VOULGARIS
KOKazuki Onishi
Kazuki Onishi
JUJunpei Ueda
Junpei Ueda
SSShigeyoshi Saito
Shigeyoshi Saito
MSMinoru Suzuki
Minoru Suzuki
In recent years, various drug delivery systems circumventing the blood–brain barrier have emerged for treating brain tumors. This study aimed to improve the efficacy of brain tumor treatment in boron neutron capture therapy (BNCT) using cerebrospinal fluid (CSF) circulation to deliver boronophenylalanine (BPA) to targeted tumors. Previous experiments have demonstrated that boron accumulation in the brain cells of normal rats remains comparable to that after intravenous (IV) administration, despite BPA being administered via CSF at significantly lower doses (approximately 1/90 of IV doses). Based on these findings, BNCT was conducted on glioma model rats at the Kyoto University Research Reactor Institute (KUR), with BPA administered via CSF. This method involved implanting C6 cells into the brains of 8-week-old Wistar rats, followed by administering BPA and neutron irradiation after a 10-day period. In this study, the rats were divided into four groups: one receiving CSF administration, another receiving IV administration, and two control groups without BPA administration, with one subjected to neutron irradiation and the other not. In the CSF administration group, BPA was infused from the cisterna magna at 8 mg/kg/h for 2 h, while in the IV administration group, BPA was intravenously administered at 350 mg/kg via the tail vein over 1.5 h. Thermal neutron irradiation (5 MW) for 20 min, with an average fluence of 3.8 × 1012/cm2, was conducted at KUR’s heavy water neutron irradiation facility. Subsequently, all of the rats were monitored under identical conditions for 7 days, with pre- and post-irradiation tumor size assessed through MRI and pathological examination. The results indicate a remarkable therapeutic efficacy in both BPA-administered groups (CSF and IV). Notably, the rats treated with CSF administration exhibited diminished BPA accumulation in normal tissue compared to those treated with IV administration, alongside maintaining excellent overall health. Thus, CSF-based BPA administration holds promise as a novel drug delivery mechanism in BNCT.

7 April 2022 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
HNHikari Nishimura
Hikari Nishimura
MSMoe Shinohara
Moe Shinohara
TMTakaaki Miyoshi
Takaaki Miyoshi
NIKOLAOS VOULGARISNIKOLAOS VOULGARIS
NIKOLAOS VOULGARIS
Sachie KusakaSachie Kusaka
Sachie Kusaka
IMIsao Murata
Isao Murata

1 September 2025 in Japanese Journal of Applied Physics
Verified
Journal Article
Open access
JQJiye Qiu
Jiye Qiu
Makoto SakaiMakoto Sakai
Makoto Sakai
NIKOLAOS VOULGARISNIKOLAOS VOULGARIS
NIKOLAOS VOULGARIS
STShingo Tamaki
Shingo Tamaki
Sachie KusakaSachie Kusaka
Sachie Kusaka
IMIsao Murata
Isao Murata
Boron neutron capture therapy (BNCT) can selectively destroy tumor cells while minimizing damage to normal tissue through boron neutron capture reactions. Real-time determination and localization of the in vivo boron dose during treatment is a critical challenge in BNCT. A promising solution involves imaging the 478 keV prompt gamma rays emitted from these capture reactions. This study presents a comprehensive simulation-based design of a Si/TlBr semiconductor Compton camera system for 478 keV prompt gamma-ray imaging in clinical BNCT. The design process includes optimization of detector geometry using isotropic, monoenergetic 478 keV gamma-ray sources; development of neutron and photon shielding under therapeutic neutron beam irradiation of a head phantom; and evaluation of imaging performance under clinically relevant conditions with low in vivo 10B concentrations. The results provide valuable insights to support the further development of Compton camera systems for BNCT applications.

3 July 2024 in Radiation
Verified
Journal Article
Open access
PDF file
NIKOLAOS VOULGARISNIKOLAOS VOULGARIS
NIKOLAOS VOULGARIS
HNHikari Nishimura
Hikari Nishimura
STShingo Tamaki
Shingo Tamaki
Sachie KusakaSachie Kusaka
Sachie Kusaka
IMIsao Murata
Isao Murata
Current radiation dosimeters sometimes face accuracy limitations or provide only cumulative doses over long periods. To contribute to this area, we developed a portable monitor that measures the energy spectrum and dose of gamma rays in real time. To achieve this, we used an improved sequential Bayesian estimation algorithm. The dose rate was then derived from the energy spectrum by applying a flux-to-dose conversion coefficient. The monitor consists mainly of a CsI(Tl) scintillator and a multi-pixel photon counter (MPPC). In developing this device, we focused on striking a balance between measurement accuracy, ease of use, and portability. As an essential aspect of the research, we investigated the influence of the CsI(Tl) crystal size on the performance of the monitor to determine an optimal size. This was accomplished by calculating the detection efficiency and energy resolution through experimental measurements using standard gamma-ray sources and simulations using MCNP5. Within the scope of the research, detector response functions were created for each crystal size for an energy range of 10 keV to 3 MeV. Considering an optimal balance of detection efficiency and energy resolution alongside a compact size suitable for portable applications, the crystal measuring 2.6 × 2.6 × 1.3 cm3 was deemed preferable.

24 June 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
JQJiye Qiu
Jiye Qiu
Makoto SakaiMakoto Sakai
Makoto Sakai
CZCaixun Zhang
Caixun Zhang
NIKOLAOS VOULGARISNIKOLAOS VOULGARIS
NIKOLAOS VOULGARIS
STShingo Tamaki
Shingo Tamaki
IMIsao Murata
Isao Murata
Objective. Boron neutron capture therapy (BNCT) is a promising radiotherapy modality that effectively targets cancer cells through boron neutron capture reactions. Real-time determination and localization of the in vivo boron dose during treatment play an important role in BNCT. This study aims to investigate the feasibility of neural network-based Compton event filtering to enhance 478 keV prompt gamma-ray imaging for BNCT under high-background radiation conditions with a Si/TlBr Compton camera. Approach. Monte Carlo simulations were performed using PHITS to generate signal and noise Compton events under clinically relevant neutron irradiation. Fully connected neural network models were trained to classify signal and noise events. The filtered events were then used for Compton image reconstruction, and quantitative imaging performance was evaluated using event retention rate with 10 B concentration and image quality metrics. Results. The neural network models achieved stable classification performance with area under the ROC curve values exceeding 0.8. The Compton event retention rate shows a strong linear relationship with tumor 10 B concentration, demonstrating the quantitative capability. Image reconstruction results indicate improved image quality in tumor regions, although additional background artifacts were observed. Significance. The proposed neural network-based Compton event filtering method provides an effective preprocessing strategy for data reduction and accelerated reconstruction. While further refinement is required for practical clinical application, this approach represents a promising step toward Compton camera-based prompt gamma-ray imaging for real-time in vivo boron dose visualization in BNCT.